In 1986, it was clear to the MetLife Foundation that the aging of America would bring a dramatic incidence of Alzheimer’s, causing untold physical, emotional, and economic suffering to patients and families and overwhelming our nation's healthcare resources.
Tackling this growing public health challenge requires new research in the field of Alzheimer’s disease. To encourage this research, MetLife Foundation established the Awards for Medical Research in Alzheimer’s Disease.
The honor roll of awardees now numbers 88 scientists – including four who have gone on to win Nobel Prizes as well as 39 winners of the prestigious Potamkin Prize. Tremendous progress has been made and our understanding of the disease continues to improve.
The awards provide outstanding researchers with an opportunity to freely pursue new ideas. At the heart of the program is a belief in research as the road to understanding and ultimately treating a devastating disease.
Questions? Visit our Frequently Asked Questions page.
Odette van der Willik, American Federation for Aging Research at 212-703-9977 or email@example.com.
Andrew B. and Gretchen P. Jones Professor and Chairman
Department of Neurology
Washington University School of Medicine
Professor of Neurology
Director of the Grossman Center for Memory Research and Care
Edmund Wallace and Anne Marie Tulloch Chairs in Neurology and Neuroscience
University of Minnesota Medical School
Professor, Hertie Institute for Clinical Brain Research & German Center for Neurodegenerative Diseases
University of Tübingen, Germany
Professor of Neurosciences
University of California, San Diego
Thomas Reynolds Sr. Professor of Neurosciences
Professor of Neurobiology and Neurology
The University of Chicago
Joseph P. and Rose F. Kennedy Professor of Neurology
Harvard Medical School
Vice-Chair, Department of Neurology, Research
Director, Genetics and Aging Research Unit,
Massachusetts General Hospital
Director, Institute on Aging
Director, Alzheimer's Disease Core Center
University of Pennsylvania
Co-Director, Center for Neurodegenerative Disease Research
Perelman School of Medicine at the University of Pennsylvania